Literature DB >> 17089090

Severe X-linked chronic granulomatous disease in two unrelated females.

Sylvie Chollet-Martin1, Anne Lopez, Catherine Gaud, Dominique Henry, Bertrand Stos, Jamel El Benna, Gaëlle Chedevile, Dominique Gendrel, Marie-Anne Gougerot-Pocidalo, Bernard Grandchamp, Bénédicte Gérard.   

Abstract

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by mutations of one of the subunits of phagocyte reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase leading to decreased or complete absence of neutrophil oxidative burst. We report the clinical and laboratory findings in two young unrelated females 14 and 9 years of age and natives of Tahiti and Reunion Islands, respectively, with severe X-linked granulomatous disease. In both cases, the infectious pattern was unusual, with convergent symptoms suggesting underlying mycobacterial infection. Functional analysis revealed low residual NADPH oxidase activity with about 5-10% of normal neutrophil population. De novo null mutations affecting the CYBB gene that encodes the gp91 protein were found in both cases in the heterozygous state (in patient 1, p.Arg130X in exon 5, and in patient 2, a novel insertion in exon 6, c.632_633insCATC). Methylation analysis confirmed that phenotype expression was linked to skewed X inactivation and showed that the de novo mutation arose on the maternally inherited chromosome in one case and on the paternally inherited chromosome in the other case. In conclusion, X-linked CGD carriers could therefore be at risk for severe infectious diseases depending on the skewed X inactivation pattern and the infectious context.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089090     DOI: 10.1007/s00431-006-0211-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Unusual late onset of X-linked chronic granulomatous disease in an adult woman after unsuspicious childhood.

Authors:  Andreas Lun; Joachim Roesler; Harald Renz
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

2.  Treatment with granulocyte colony-stimulating factor for pneumonia in a patient with a variant form of X-linked chronic granulomatous disease.

Authors:  T Fukuda; S Kitagawa; E Azuma; A Yuo; N Kawamata; T Miki; S Hirosawa; N Aoki
Journal:  Eur J Haematol       Date:  1995-07       Impact factor: 2.997

Review 3.  Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease.

Authors:  S Córdoba-Guijarro; C Feal; E Daudén; J Fraga; A García-Díez
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-09       Impact factor: 6.166

4.  X-linked chronic granulomatous disease in an adult woman. Evidence for a cell selection favoring neutrophils expressing the mutant allele.

Authors:  M Cazzola; F Sacchi; A Pagani; M Marconi; M M Ciriello; A Fietta; A Clivio; E Ascari
Journal:  Haematologica       Date:  1985 Jul-Aug       Impact factor: 9.941

5.  Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).

Authors:  B Gérard; J El Benna; F Alcain; M A Gougerot-Pocidalo; B Grandchamp; S Chollet-Martin
Journal:  Hum Mutat       Date:  2001-08       Impact factor: 4.878

6.  Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.

Authors:  A Rösen-Wolff; W Soldan; K Heyne; J Bickhardt; M Gahr; J Roesler
Journal:  Ann Hematol       Date:  2001-02       Impact factor: 3.673

7.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

Authors:  L Busque; R Mio; J Mattioli; E Brais; N Blais; Y Lalonde; M Maragh; D G Gilliland
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

8.  Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.

Authors:  M Kaneda; H Sakuraba; A Ohtake; A Nishida; C Kiryu; K Kakinuma
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

9.  Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease.

Authors:  G R Yeaman; K Froebel; G Galea; A Ormerod; S J Urbaniak
Journal:  Br J Dermatol       Date:  1992-01       Impact factor: 9.302

10.  Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation.

Authors:  Mindy Anderson-Cohen; Steve M Holland; Doug B Kuhns; Thomas A Fleisher; Li Ding; Sebastian Brenner; Harry L Malech; Joachim Roesler
Journal:  Clin Immunol       Date:  2003-12       Impact factor: 3.969

View more
  6 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

Review 2.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 3.  Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.

Authors:  A C Battersby; A M Cale; D Goldblatt; A R Gennery
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

4.  Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease.

Authors:  Preeti Jaggi; Rebecca Scherzer; Rose Knieper; Hayat Mousa; Vinay Prasad
Journal:  J Clin Immunol       Date:  2011-11-17       Impact factor: 8.317

5.  X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.

Authors:  Eric M Lewis; Manav Singla; Susan Sergeant; Patrick P Koty; Linda C McPhail
Journal:  Clin Immunol       Date:  2008-09-06       Impact factor: 3.969

6.  Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019.

Authors:  Wen-I Lee; Cheng-Hsun Chiu; Chao-Yi Wu; Yi-Ching Chen; Jing-Long Huang; Li-Chen Chen; Liang-Shiou Ou; Tsung-Chieh Yao; Tang-Her Jaing; Shih-Hsiang Chen; Chi-Jou Liang; Chen-Chen Kang
Journal:  J Clin Immunol       Date:  2021-05-08       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.